Relating acute esophagitis to radiotherapy dose using FDG-PET in concurrent chemo-radiotherapy for locally advanced non-small cell lung cancer.
暂无分享,去创建一个
Jan-Jakob Sonke | Jasper Nijkamp | Jose Belderbos | Margriet Kwint | J. Sonke | J. Lebesque | J. Belderbos | M. Rossi | M. M. van den Heuvel | M. Kwint | W. Vogel | J. Nijkamp | Maddalena Rossi | Joos Lebesque | Michel van den Heuvel | Wilma Uyterlinde | Wouter Vogel | W. Uyterlinde
[1] R. Mohan,et al. Predictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer. , 2012, International journal of radiation oncology, biology, physics.
[2] Jan-Jakob Sonke,et al. Acute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapy. , 2012, International journal of radiation oncology, biology, physics.
[3] B. Bergman,et al. Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab--pooled results from two prospective clinical trials. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] R. Castillo,et al. [18F]-FDG uptake dose-response correlates with radiation pneumonitis in lung cancer patients. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[5] J. Aerts,et al. A randomized, multicenter phase II study investigating additional weekly cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: Reporting on the efficacy. , 2012 .
[6] J. Aerts,et al. OC-0498 CONCURRENT CHEMORADIOTHERAPY WITH OR WITHOUT CETUXIMAB IN NSCLC; TOXICITY RESULTS OF A RANDOMIZED PHASE II TRIAL , 2012 .
[7] R. Mohan,et al. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience. , 2012, International journal of radiation oncology, biology, physics.
[8] M. Othus,et al. Esophagus in-field: a new predictor for esophagitis. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] A. Alavi,et al. PET and PET-CT imaging in infection and inflammation: its critical role in assessing complications related to therapeutic interventions in patients with cancer. , 2010, Indian journal of cancer.
[10] Jose Belderbos,et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] M. van Herk,et al. The Accuracy of Deformable Registration for Adaptive Radiotherapy of Head and Neck Cancer , 2009 .
[12] J. Sonke,et al. Target volume shape variation during hypo-fractionated preoperative irradiation of rectal cancer patients. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[13] S. Targan,et al. Molecular imaging of murine intestinal inflammation with 2-deoxy-2-[18F]fluoro-D-glucose and positron emission tomography. , 2008, Gastroenterology.
[14] V A Semenenko,et al. Lyman–Kutcher–Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data , 2008, Physics in medicine and biology.
[15] E. Dieleman,et al. Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration. , 2007, International journal of radiation oncology, biology, physics.
[16] J. Karp,et al. Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] Jan-Jakob Sonke,et al. Mid-ventilation CT scan construction from four-dimensional respiration-correlated CT scans for radiotherapy planning of lung cancer patients. , 2006, International journal of radiation oncology, biology, physics.
[18] Tae Hyun Kim,et al. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy. , 2005, International journal of radiation oncology, biology, physics.
[19] Jose Belderbos,et al. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[20] A. Alavi,et al. Radiation-induced esophagitis on FDG PET imaging. , 2003, Clinical nuclear medicine.
[21] L. Boersma,et al. Pulmonary function following high-dose radiotherapy of non-small-cell lung cancer. , 2003, International journal of radiation oncology, biology, physics.
[22] Joos V Lebesque,et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. , 2003, International journal of radiation oncology, biology, physics.
[23] R. Jaszczak,et al. The role of lung perfusion imaging in predicting the direction of radiation‐induced changes in pulmonary function tests , 2000, Cancer.
[24] P Baas,et al. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[25] R W de Boer,et al. Estimation of overall pulmonary function after irradiation using dose-effect relations for local functional injury. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[26] C. Burman,et al. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. , 1989, International journal of radiation oncology, biology, physics.
[27] S. Moolgavkar,et al. A Method for Computing Profile-Likelihood- Based Confidence Intervals , 1988 .
[28] J. Lyman. Complication Probability as Assessed from Dose-Volume Histograms , 1985 .